Piper Jaffray Updates From SAGES Meetings

Piper Jaffray has issued a report on the takeaways from the SAGES industry meeting in regards to C.R. Bard BCR. According to the report, "Discussions with BCR management at the SAGES industry meeting support our projections for above market growth for the Surgical Specialties division in 2011. Highlights from the meeting include the launch of its Echo PS mesh positioning system and the full recovery of its XenMatrix product after a recall earlier this year. We remain at Neutral with no near-term catalysts to drive the stock higher." BCR has a $93 PT and closed yesterday at $99.36 a share.